{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T03:59:29Z","timestamp":1754020769558},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,2,15]]},"DOI":"10.2169\/internalmedicine.5125-20","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:06:18Z","timestamp":1602021978000},"page":"617-621","source":"Crossref","is-referenced-by-count":5,"title":["Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis"],"prefix":"10.2169","volume":"60","author":[{"given":"Mari","family":"Takahashi","sequence":"first","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Horio","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Takihara","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keito","family":"Enokida","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Miyaoka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Hirabayashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Ohshinden","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Hattori","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminari","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Takiguchi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Niimi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hayama","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Oguma","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Asano","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 161: 5-8, 2000.","DOI":"10.1164\/ajrccm.161.1.9906062"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Natsuizaka M, Chiba H, Kuronuma K, et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med 190: 773-779, 2014.","DOI":"10.1164\/rccm.201403-0566OC"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ulke HM, Mutze K, Lehmann M, et al. The Oncogene ECT2 contributes to a hyperplastic, proliferative lung epithelial cell phenotype in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 61: 713-726, 2019.","DOI":"10.1165\/rcmb.2019-0047OC"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Basu A, Contreras AG, Datta D, et al. Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer. Cancer Res 68: 5689-5698, 2008.","DOI":"10.1158\/0008-5472.CAN-07-6603"},{"key":"5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","volume":"397","author":"M Hojo","year":"1999","unstructured":"5. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397: 530-534, 1999.","journal-title":"?Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zhou AY, Ryeom S. Cyclosporin A promotes tumor angiogenesis in a calcineurin-independent manner by increasing mitochondrial reactive oxygen species. Mol Cancer Res 12: 1663-1676, 2014.","DOI":"10.1158\/1541-7786.MCR-14-0136"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Natkunam Y, Gratzinger D, Chadburn A, et al. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal? Blood 132: 1871-1878, 2018.","DOI":"10.1182\/blood-2018-04-842559"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. D&apos;Arcy ME, Coghill AE, Lynch CF, et al. Survival after a cancer diagnosis among solid organ transplant recipients in the United States. Cancer 125: 933-942, 2019.","DOI":"10.1002\/cncr.31782"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Geissler EK. Post-transplantation malignancies: here today, gone tomorrow? Nat Rev Clin Oncol 12: 705-717, 2015.","DOI":"10.1038\/nrclinonc.2015.186"},{"key":"10","unstructured":"10. Tseng HW, Lu LY, Lam HC, Tsai KW, Huang WC, Shiue YL. The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan. Clin Exp Rheumatol 36: 471-478, 2018."},{"key":"11","unstructured":"11. Tseng HW, Huang WC, Lu LY. The influence of immunosuppressants on the non-melanoma skin cancer among patients with systemic lupus erythematosus and primary Sj\u00f6gren&apos;s syndrome: a nationwide retrospective case-control study in Taiwan. Clin Exp Rheumatol 37: 946-952, 2019."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kako S, Izutsu K, Oshima K, et al. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer\/T cell lymphoma following allogeneic hematopoietic stem cell transplantation. Am J Hematol 82: 937-939, 2007.","DOI":"10.1002\/ajh.20943"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Ohguchi H, Sai T, Hamazaki Y, Hiwatashi K. [Cyclosporin A withdrawal causes spontaneous remission of recurrent subcutaneous tumors after allogeneic peripheral blood stem cell transplantation for adult T-cell leukemia\/lymphoma]. Rinsho Ketsueki 44: 102-107, 2003 (in Japanese, Abstract in English).","DOI":"10.11406\/rinketsu.44.102"},{"key":"14","unstructured":"14. Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8: 128-135, 2002."},{"key":"15","unstructured":"15. Kawamura K, Ichikado K, Muranaka H, et al. [Solid malignancy in patients who received cyclosporine for fibrosing interstitial pneumonia]. Nihon Kokyuki Gakkai Zasshi 48: 261-266, 2010 (in Japanese, Abstract in English)."},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Usuda K, Saito Y, Sagawa M, et al. Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer 74: 2239-2244, 1994.","DOI":"10.1002\/1097-0142(19941015)74:8<2239::AID-CNCR2820740806>3.0.CO;2-P"},{"key":"17","unstructured":"17. Ogawa R, Watanabe H, Yazaki K, et al. Lung cancer with spontaneous regression of primary and metastatic sites: a case report. Oncol Lett 10: 550-552, 2015."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Takano M, Yamamoto C, Yamaguchi K, Kawami M, Yumoto R. Analysis of TGF-beta1- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE\/Abca3. Drug Metab Pharmacokinet 30: 111-118, 2015.","DOI":"10.1016\/j.dmpk.2014.10.007"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mooradian DL, McCarthy JB, Komanduri KV, Furcht LT. Effects of transforming growth factor-beta 1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro. J Natl Cancer Inst 84: 523-527, 1992.","DOI":"10.1093\/jnci\/84.7.523"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Burghardt I, Tritschler F, Opitz CA, Frank B, Weller M, Wick W. Pirfenidone inhibits TGF-beta expression in malignant glioma cells. Biochem Biophys Res Commun 354: 542-547, 2007.","DOI":"10.1016\/j.bbrc.2007.01.012"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67, 2010.","DOI":"10.1016\/j.cell.2010.03.015"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Azuma H, Ehata S, Miyazaki H, et al. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC (A) cells. J Natl Cancer Inst 97: 1734-1746, 2005.","DOI":"10.1093\/jnci\/dji399"},{"key":"23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12885-016-2162-z","volume":"16","author":"M Mediavilla-Varela","year":"2016","unstructured":"23. Mediavilla-Varela M, Boateng K, Noyes D, Antonia SJ. The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts. BMC Cancer 16: 176, 2016.","journal-title":"BMC Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/4\/60_5125-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T03:49:39Z","timestamp":1613792979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/4\/60_5125-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5125-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}